Search
Now showing items 1-10 of 44
Comparison Of Myelodysplastic Syndrome Prognostic Scoring Systems
(2016)
Objective: Myelodysplastic syndrome (MDS) is a clonal hematopoietic stem cell disease. Patients are at risk of developing cytopenias or progression to acute myeloid leukemia. Different classifications and prognostic scoring ...
Indications And Outcomes Of Splenectomy For Hematological Disorders
(2019)
Background and Aim Splenectomy is a frequent component of the diagnosis and treatment of hematological disorders. The aim of this study was to define the indications and outcomes of splenectomy for benign and malign ...
Comparison Of Myeloablative Versus Reduced-Intensity Conditioning Regimens For Allogeneic Hematopoietic Stem Cell Transplantation In Acute Myeloid Leukemia: A Cohort Study
(2019)
Objective: Allogeneic hematopoietic stem cell transplantation (HSCT) is an effective treatment modality for a variety of malignant and non-malignant hematologic disorders. Myeloablative conditioning (MAC) and reduced-intensity ...
Unclassifiable Non-Cml Classical Myeloproliferative Diseases With Microcytosis: Findings Indicating Diagnosis Of Polycythemia Vera Masked By Iron Deficiency
(2019)
Background/aim Polycythemia Vera (PV) is a myeloproliferative disorder characterized by overproduction of morphologically normal red blood cells (RBCs), granulocytes, and platelets, a phenotype that is caused by a mutation ...
The Factors Affecting Early Death In Newly Diagnosed Apl Patients
(2019)
Background and aim: In the past, acute promyelocytic leukemia (APL) was considered as one of the most rapidly lethal form of acute myeloid leukemia (AML). The objective of this study was to assess clinical parameters ...
Mitoxantrone-Melphalan Conditioning Regimen For Autologous Stem Cell Transplantation In Relapsed/Refractory Lymphoma
(2019)
Background/aim High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) has become the standard approach for patients with relapsed/refractory Hodgkin’s lymphoma (HL) or non-Hodgkin’s lymphoma (NHL). ...
Effects Of Ankaferd Hemostat On Red Blood Cell Aggregation: A Hemorheological Study
(2019)
Background/aim: Ankaferd hemostat (ABS; Ankaferd blood stopper, Istanbul, Turkey) is a prohemostatic agent affecting erythrocytes. The hemostatic action of ABS depends upon fibrinogen gamma chain, prothrombin, and red blood ...
The Impact Of Jak/Stat Inhibitor Ruxolitinib On The Genesis Of Lymphoproliferative Diseases
(2019)
Background/aim Ruxolitinib, a JAK/STAT signaling pathway inhibitor targeted drug, has been approved for the controlling of disease symptoms and splenomegaly in patients with myeloproliferative neoplastic diseases. Recently, ...
Fibrosis Development, Leukemic Transformation And Secondary Malignancies Complicating The Clinical Course Of Essential Thrombocythemia
(2019)
Essential thrombocythemia (ET) is a myeloproliferative neoplastic disease characterized by abnormal proliferation of megakaryocytes in the bone marrow leading to elevated platelet counts in the peripheral blood. In the ...
Naturally Acquired Hepatitis a Antibodies After Haematopoetic Stem Cell Transplantation
(Cambridge University Press, 2011)
Haematopoietic stem cell transplant (HSCT) recipients lose immune memory of exposure to
infectious agents and vaccines accumulated throughout their lifetime and therefore need to be
revaccinated. We aimed to evaluate the ...
